Bid guide
How to bid on GEM-X Single Cell 5’ Gene Expression Kits for NIH
What the NIH is buying and why it matters
The National Institutes of Health (NIH) intends to purchase GEM-X Single Cell 5’ Gene Expression Kits and companion reagents from 10x Genomics. These supplies include kits for 48 and 4 samples, Chromium GEM-X Single Cell 5’ Chip Kits, and Dual Index Kit TT Set A Kits.
These items are needed to analyze single-cell/single-nucleus gene expression profiles from approximately 96 individuals. The goal is to identify molecular risk factors, regulatory mechanisms, and potential therapeutic targets for cardiometabolic diseases. The NIH states that maintaining compatibility with existing data and established assay workflows from the 10x Genomics platform is necessary.
Key dates and what happens at the deadline
This Request for Information (RFI) was published on September 11, 2026. Capability statements must be submitted electronically by September 21, 2026, at 9:00 AM EDT.
The NIH anticipates making an award approximately five calendar days after this closing date, unless they determine that another responsible source can meet the requirement. This notice is not a request for competitive quotations, but the NIH will consider all timely capability statements to decide if the acquisition should proceed as a sole-source procurement or be competed.
Who this opportunity suits
This opportunity is primarily for suppliers who can provide the specified GEM-X Single Cell 5’ Gene Expression Kits and companion reagents from 10x Genomics. The NIH has indicated that 10x Genomics is the sole manufacturer and authorized source for these proprietary products, which are required for compatibility with existing research workflows and data.
However, other interested parties who believe they can meet all technical and operational requirements for these specific equipment and reagents are encouraged to submit a capability statement.
How to respond to this RFI
To respond, you must submit a capability statement electronically. Your statement should demonstrate your ability to provide the required supplies and meet all specified technical and operational requirements.
Send your capability statement to [email protected]. Ensure you reference Notice No. 75N98026Q01198 in the subject line of your email. The deadline for submission is September 21, 2026, at 9:00 AM EDT.
Tips for preparing a competitive response
Even for a potential sole-source procurement, a well-prepared capability statement is crucial. Clearly articulate how your firm can meet every single requirement listed in the solicitation. Do not assume the agency knows your capabilities; explicitly state them.
Focus on demonstrating your ability to provide the exact products specified, including the specific kits and reagents. If you are not 10x Genomics, you must clearly explain how you can supply these proprietary items and ensure compatibility with the existing 10x Genomics-based research workflow and previously collected data, as this is a key requirement for the NIH.
See the live bid — deadline, agency details, and how to respond
Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.
View this bid on BiddingSimpleThis guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from National Institutes of Health; the original posting controls.